Coagulopathic Effects and Therapy of Brodifacoum Toxicosis in Dogs

The clinical signs and laboratory changes of brodifacoum (BDF) intoxicated dogs and their response to vitamin K1 treatment were examined. Brodifacoum, a second-generation anticoagulant rodenticide, was fed to four dogs for 3 consecutive days producing a cumulative dose of 1.1 mg BDF/kg body weight. Clinical observations of the animals were made daily throughout the study. Monitored laboratory parameters included: one-stage prothrombin time (OSPT), activated partial thromboplastin time (APTT), activated coagulation time (ACT), complete blood counts, thrombocyte counts, and serum chemistry values. Response to vitamin K1 therapy was evaluated clinically and by laboratory tests. Serum BDF concentrations were monitored. Inappetence and hemorrhagic tendencies were exhibited by day 5 postrodenticide exposure. One-stage prothrombin time, APTT, and ACT were 25% greater than time zero values at 24, 24, and 72 hours postdosing, respectively. All laboratory parameters returned to normal within 48 hours of initiating vitamin K1 therapy (0.83 mg/kg orally, TID for 5 days). Serum brodifacoum concentrations were highest (1065-1215 ng/mL) during the 3 days after BDF dosing and were detectable (3.0-7.5 ng/mL) until day 24 postexposure. A mean BDF elimination half-life of 6 +/- 4 days was observed.     

DEGENERATIVE CHANGES IN THE VERTEBRAL COLUMN OF THE DOG

A group of 160 Beagles were studied radiographically to determine the pattern of degenerative changes within the vertebral column, especially involving the intervertebral discs. The normal radiographic appearance of both disc and surrounding vertebrae is described. Disc space narrowing and calcification of discal tissues provide radiographic patterns that assist in diagnosis and prognosis. Because of the older age of the dogs, severe degeneration of the endplates with marked instability between vertebral segments was seen.     

TRANSABDOMINAL SONOGRAPHIC EVALUATION OF THE CANINE PROSTATE

The present study sought to determine the accuracy of ultrasonographic measurement of the prostate; to observe the ultrasonographic appearance of the normal prostate; and to compare these observations with those in prostates affected by cystic hyperplasia, benign hyperplasia, land neoplasia. Trassabdominal ultrasonography of the canine prostate was performed in eight normal dogs to establish criteria for evaluating enlarged prostates. Marginal boundries, size, and ultrasonographic architecture were compared with dissection findings to assess the accuracy of ultrasonography. Four enlarged prostates were evaluated ultrasonographically, and the findings were correlated with results of needle aspiration and urethral wash and with surgical and histopathologic findings. Differentiation between cystic and solid prostatic enlargement by ultrasonography proved efective. Transducer frequency and gain manipulation were important factors in describing the nature of the fluid within a cyst. Assenssment of the nature of solid prostatic enlargement and accurate size determination proved to be areas in which ultrasonography should by used in conjunction with other diagnostic techniques.     

PSITTACINE SKULL RADIOGRAPHY

The psittacine skull is a complex anatomic structure, frequently traumatized but difficult to adequately image with standard radiographic procedures. Multiple views including a ventrodorsal, a lateral, and complementary oblique projections are necessary to fully evaluate potential skull fractures in the avian patient. Magnification radiography is a relatively easy procedure that aids the review of small osseous structures. Familiarity with psittacine skull anatomy greatly facilitates radiographic interpretation of cranial trauma.     

Evaluation of a Collagenase Generated Osteoarthritis Biomarker in Naturally Occurring Canine Cruciate Disease

Objective— To determine the clinical value of a novel osteoarthritis (OA) biomarker in detecting canine cruciate disease.
Study Design— Cross sectional clinical study.
Animals— Dogs (n=22) with cranial cruciate ligament (CCL) rupture and 12 control dogs.
Methods— Concentrations of collagenase-generated cleavage epitope of type II collagen (Col2-3/4C_{long mono}, or C2C) in serum, urine, and joint fluid were compared between a group of dogs with CCL rupture and a control group. Correlation of C2C concentrations to the clinical stage of stifle OA was also evaluated.
Results— There were no significant differences in C2C concentrations in serum, urine, and joint fluid between groups ( P >.05). Subjective scores of lameness, joint effusion, osteophytosis were significantly more severe in the CCL rupture group compared with the control group ( P <.05). There was no significant correlation of C2C concentrations with clinical stage of stifle OA ( P >.05).
Conclusion— This OA biomarker did not detect pathology associated with CCL rupture. Our results suggest that collagenase-specific degradation of type II collagen in articular cartilage may not be involved in the early stage of naturally occurring canine cruciate disease, and that pathology associated with naturally occurring CCL rupture is different from that of experimental OA model.
Clinical Relevance— C2C is not clinically useful in detecting CCL rupture in dogs.     

Age, Tibial Plateau Angle, Sex, and Weight as Risk Factors for Contralateral Rupture of the Cranial Cruciate Ligament in Labradors

Objective— To compare rates of contralateral cranial cruciate ligament rupture (CCLR) in Labradors based on age and weight at initial rupture, sex, and tibial plateau angle (TPA) and to determine whether Labradors that rupture their initial cranial cruciate ligament (CCL) at an earlier age (<4 years) are more likely to rupture their contralateral side within a certain period of time. Study Design— Case series. Animals— Labradors (n=94) that had tibial plateau leveling osteotomy (TPLO). Methods— Two groups: no contralateral rupture (NR) and contralateral rupture (CR) were compared for significant (P<.05) differences in percentage of subsequent cruciate tears using a Wilcoxon's rank‐sum tests for continuous variables and Fisher's exact test for sex. Adjusted odds ratios for likelihood of subsequent cruciate tears (yes/no) were estimated using logistic regression. Associations of these characteristics with time to subsequent rupture were assessed using Kaplan–Meier survival analysis estimation. Predictors of presentation with bilateral ruptures (BR) versus single rupture were also evaluated using Wilcoxon's rank‐sum tests and a generalized Fisher's exact test. Results— Subsequent CCLR occurred in 45 dogs (48%), and BR on admission were identified in 10 dogs (10.6%). Comparing NR and CR dogs, there were no significant differences between age or weight at initial rupture, sex or TPA; however there were associations toward longer time to CR for dogs older than the median age and female dogs (intact and spayed). There were no significant differences in age, sex, weight, or TPA of dogs with bilateral CCL ruptures compared with initial unilateral ruptures; however, there was a trend toward dogs presenting at an older age and with lower TPA's in the BR group. Among the 84 NR/CR dogs, the median time to rupture of the contralateral CCL was 5.5 months (95% CI 5.2–5.7). Conclusions— Age and weight at initial rupture, sex, and TPA does not affect likelihood or rate of contralateral CCL rupture or presentation with bilateral CCL ruptures. Clinical Relevance— Approximately 50% of Labradors will rupture the contralateral CCL within 5.5 months of the initial rupture but age, weight, sex, and TPA cannot be used as predictive features.     

HEMOPOIETIC RESPONSES OF THE CAT TO TOTAL BODY IRRADIATION FOLLOWED BY CHEMOTHERAPY

Cats with lymphosarcoma are affected with rapidly progressive, fatal neoplasia of hemopoietic tissues. The very aggressive nature of this type of neoplasia requires intense therapy, which in most instances is only palliative. A combination of total body irradiation and cytotoxic chemotherapy in four normal cats was followed by similar patterns of leukopenia and throm-bocytopenia in all cats. The radiation protocol and the complications of the transient throm-bocytopenia and leukopenia are discussed and compared with reports of similar efforts in human medicine. The responses from these normal cats were quite similar to those seen in humans undergoing similar therapy. The cat may be considered as a possible model for further radiotherapy research.